Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373893 · ClinicalTrials.gov registry record · Phase 1
Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia
A Phase 1 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00373893 is a Phase 1 study that has completed, run by University of California, San Diego. The registered enrollment target is 12 participants.
The verdict
NCT00373893, a Phase 1 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
To determine the effects of Lidocaine patch on the pain and hyperalgesia induced by intradermal capsaicin
Interventions
- DRUG Lidoderm Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-12 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373893
The ClinicalTrials.gov registry entry for NCT00373893 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidoderm Patch is the first listed.
NCT00373893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00373893 about?
NCT00373893 is a clinical study titled "Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia". To determine the effects of Lidocaine patch on the pain and hyperalgesia induced by intradermal capsaicin
What is the current status of trial NCT00373893?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2005-12. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00373893?
The interventions under investigation include: Lidoderm Patch (DRUG).
Who is sponsoring clinical trial NCT00373893?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.